Phase 3 Systemic Sclerosis Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Interstitial Lung DiseaseSystemic Sclerosis
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland86 enrolled1 locationNCT06297096
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 3
Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma
Intervention StudySystemic Sclerosis (SSc)Mediciine
Khon Kaen University36 enrolled1 locationNCT07245238
Recruiting
Phase 2Phase 3
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux90 enrolled10 locationsNCT05098704
Recruiting
Phase 3
Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh24 enrolled1 locationNCT06936215
Terminated
Phase 3
Scleroderma-Pulmonary Arterial Hypertension Intervention with Apixaban: The SPHInX Study
Pulmonary Arterial HypertensionSystemic Sclerosis
St Vincent's Hospital Melbourne Pty Ltd170 enrolled14 locationsACTRN12614000418673